Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J(2023) Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants Cell Rep, 42(1), 111995(in press) DOI 10.1016/j.celrep.2023.111995, PubMed 36656713
Skånland SS, Brown JR(2023) PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here? Haematologica, 108(1), 9-21 DOI 10.3324/haematol.2022.281266, PubMed 35899388
Lyng H, Skipar K, Hompland T(2022) Targeted Therapy on the Screen: Do We Hit the Target? Clin Cancer Res, 28(24), 5233-5234 DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006